Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis B

PHASE2CompletedINTERVENTIONAL

Enrollment

220

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions

Hepatitis B, Chronic

Interventions

DRUG

pradefovir mesylate

DRUG

adefovir dipivoxyl

All Listed Sponsors

lead

Bausch Health Americas, Inc.

INDUSTRY

NCT00230503 - Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis B | Biotech Hunter | Biotech Hunter